5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
A clinical review of GHK-Cu (copper tripeptide) efficacy differences in East Asian patients, covering pharmacogenomics, ethnicity-stratified data, dosing considerations, and what providers need to know before prescribing.
Evidence review of GHK-Cu (copper tripeptide) efficacy in Black and African ancestry populations, covering pharmacogenomic factors, melanin-rich skin penetration, G6PD prevalence, and dosing guidance.
Evidence-based review of GHK-Cu (copper tripeptide) efficacy in Hispanic and Latino populations, covering pharmacogenomics, copper metabolism variants, dosing considerations, and clinical gaps in ethnicity-stratified data.
A clinical review of GHK-Cu copper tripeptide dosing for South Asian patients, covering pharmacogenomics, metabolic risk factors, ethnicity-stratified data, and practical prescribing guidance.
A clinical deep-dive into how GHK-Cu (copper tripeptide) may behave differently in South Asian patients, covering pharmacogenomics, copper metabolism, dosing considerations, and ethnicity-specific safety signals.